Oncotarget is a medical journal that has open access. It has gained popularity due to its multiple peer-reviewed, insightful, punctual, and constructive approaches. Oncotarget was established in 2010. It covers research on all areas of oncology. The editors-in-chief at Oncotarget are Andrei V. Gudkov and Mikhail Blagosklonny. Andrew Schally and Carlo M. Croce serve on the journal’s editorial board and have published some papers in Oncortarget. They both won the Breakthrough Prize. Oncotarget is ranked the first position among all oncology journals. Oncotarget usually publishes papers online every week. Oncotarget allows readers to print any issue or paper in cases of special demand.
Oncotarget has recently started taking papers which are on topics more than oncology. These include cardiology, cell biology, endocrinology, metabolism, and pharmacology. Oncotarget has the most prominent scientists as its leaders, and they have been able to steer the journal to success. The main aim of Oncotarget is to avail scientific results rapidly and also make them widely available. The journal also seeks to maximize research impact through insightful review. Oncotarget also enables quick sharing of exceptional discoveries and removes the border that exists between specialties. The oncology journal also links various fields when it comes to biomedical science. Read more journals on Dove Press.
Oncotarget’s mission is to foster applications of clinical and basic science so as to fight disease. Life with no disease is Oncotarget’s ultimate goal. Oncotarget focuses on the pathological basis of every type of cancer, treatment protocols, and possible therapy targets so as to enhance cancer management in patients. Oncotarget also concentrates on the impact of new therapeutic protocols and agents and management programs for patients with adherence, quality of life, and satisfaction. Oncotarget has been able to acquire a massive fan base due to insightful and informative content. The journal encourages upcoming scientists to send their articles. They get published if they qualify.
Oncotarget has become the go-to journal for those who wish to know all issues concerning oncology. The Journal has an easy to operate website whereby readers can get to read papers and issues online. Oncotarget continues to implement its strategic plans for providing their readers with comprehensive and detailed information. Follow Oncotarget on Twitter.